| pubmed-article:18533797 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18533797 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:18533797 | lifeskim:mentions | umls-concept:C0002871 | lld:lifeskim |
| pubmed-article:18533797 | lifeskim:mentions | umls-concept:C0036043 | lld:lifeskim |
| pubmed-article:18533797 | lifeskim:mentions | umls-concept:C0357131 | lld:lifeskim |
| pubmed-article:18533797 | lifeskim:mentions | umls-concept:C1552617 | lld:lifeskim |
| pubmed-article:18533797 | lifeskim:mentions | umls-concept:C0282443 | lld:lifeskim |
| pubmed-article:18533797 | lifeskim:mentions | umls-concept:C0558293 | lld:lifeskim |
| pubmed-article:18533797 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:18533797 | pubmed:dateCreated | 2008-6-6 | lld:pubmed |
| pubmed-article:18533797 | pubmed:abstractText | Epoetin beta effectively increases hemoglobin levels, reduces the need for transfusions and improves the quality of life in patients with symptomatic chemotherapy-induced anemia with a range of solid tumors and lymphoid malignancies. Recent evidence-based guidelines recommend the once weekly administration of epoetin beta. This once-weekly regimen is generally well tolerated, and studies to date have reported that epoetin beta has a neutral effect on survival of patients with cancer. The once-weekly administration regimen is convenient for the physician and patient alike. Methods to further optimize this treatment are discussed. | lld:pubmed |
| pubmed-article:18533797 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18533797 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18533797 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18533797 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18533797 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18533797 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18533797 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18533797 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18533797 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18533797 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18533797 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:18533797 | pubmed:issn | 1744-8328 | lld:pubmed |
| pubmed-article:18533797 | pubmed:author | pubmed-author:SpaëthDominiq... | lld:pubmed |
| pubmed-article:18533797 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:18533797 | pubmed:volume | 8 | lld:pubmed |
| pubmed-article:18533797 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18533797 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18533797 | pubmed:pagination | 875-85 | lld:pubmed |
| pubmed-article:18533797 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:18533797 | pubmed:meshHeading | pubmed-meshheading:18533797... | lld:pubmed |
| pubmed-article:18533797 | pubmed:meshHeading | pubmed-meshheading:18533797... | lld:pubmed |
| pubmed-article:18533797 | pubmed:meshHeading | pubmed-meshheading:18533797... | lld:pubmed |
| pubmed-article:18533797 | pubmed:meshHeading | pubmed-meshheading:18533797... | lld:pubmed |
| pubmed-article:18533797 | pubmed:meshHeading | pubmed-meshheading:18533797... | lld:pubmed |
| pubmed-article:18533797 | pubmed:meshHeading | pubmed-meshheading:18533797... | lld:pubmed |
| pubmed-article:18533797 | pubmed:meshHeading | pubmed-meshheading:18533797... | lld:pubmed |
| pubmed-article:18533797 | pubmed:meshHeading | pubmed-meshheading:18533797... | lld:pubmed |
| pubmed-article:18533797 | pubmed:meshHeading | pubmed-meshheading:18533797... | lld:pubmed |
| pubmed-article:18533797 | pubmed:meshHeading | pubmed-meshheading:18533797... | lld:pubmed |
| pubmed-article:18533797 | pubmed:meshHeading | pubmed-meshheading:18533797... | lld:pubmed |
| pubmed-article:18533797 | pubmed:meshHeading | pubmed-meshheading:18533797... | lld:pubmed |
| pubmed-article:18533797 | pubmed:meshHeading | pubmed-meshheading:18533797... | lld:pubmed |
| pubmed-article:18533797 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18533797 | pubmed:articleTitle | Epoetin beta once weekly: review of its efficacy and safety in patients with chemotherapy-induced anemia. | lld:pubmed |
| pubmed-article:18533797 | pubmed:affiliation | Oncologie Médicale, Centre d'Oncologie de Gentilly, 2 rue Marie Marvingt, 54100 Nancy, France. oncomed@wanadoo.fr | lld:pubmed |
| pubmed-article:18533797 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18533797 | pubmed:publicationType | Review | lld:pubmed |
| pubmed-article:18533797 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18533797 | lld:pubmed |
